• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.26% Nasdaq Up 0.49%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.69 Down 0.04(2.31%) 1:14PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.73
    Open:1.75
    Bid:1.69 x 49900
    Ask:1.70 x 1200
    1y Target Est:4.56
    Beta:1.1
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:1.68 - 1.77
    52wk Range:0.97 - 2.12
    Volume:189,609
    Avg Vol (3m):1,268,720
    Market Cap:253.79M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 2.31%253.79M
    LLYUp 0.18%76.86B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):56.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback